患者决策辅助工具对乳腺癌切除后重建决策的效果:随机对照试验
这项单中心随机对照试验纳入134例适合乳房切除后重建(PMBR)的女性,1:1分为标准护理组和标准护理联合PMBR特异性患者决策辅助(pDA)组。主要结局为决策后决策冲突,两组均持续较低(17 vs 20),主要结局(MD -2.8,95%CI -8.4至2.8,Cohen's d -0.18)及次要结局均无显著差异。在可及高质量多学科护理的人群中,在线pDA未较标准护理提供额外获益。
要点
- 在高质量多学科护理背景下,PMBR特异性在线pDA未额外降低决策冲突。
- 标准护理与pDA均使决策冲突持续处于低水平(17 vs 20)。
- 主要和次要结局在决策后即刻及术后1年均无显著组间差异。
核心结论
- 在可及高质量多学科护理的人群中,在线PMBR特异性pDA较标准护理未提供额外获益。
- 标准护理与pDA均有效支持重建决策,决策冲突持续处于低水平。
研究设计与样本
- 单中心随机对照试验,女性按1:1分配至标准护理组(对照)或标准护理联合pDA组(干预)。
- 共纳入134例适合PMBR的女性(干预组66例,对照组68例)。
- 基线、重建决策后及术后1年完成问卷,主要结局为决策后决策冲突。
主要发现
- 两组决策冲突持续较低(17 vs 20)。
- 主要结局无显著差异(MD -2.8,95%CI -8.4至2.8,Cohen's d -0.18)。
- 次要结局在重建决策后即刻及术后1年均无显著差异。
临床怎么用
- 在已具备高质量多学科护理的中心,PMBR决策支持可沿用标准护理流程。
- 在线pDA可作为可选辅助工具,但不应预期其额外降低决策冲突。
局限性
- 单中心设计可能限制结果外推性。
- 研究人群为可及高质量多学科护理者,结论不适用于缺乏此类护理的环境。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-mastectomy breast reconstruction (PMBR) improves quality of life, yet decisions regarding type and timing are complex, requiring careful consideration of risks, benefits, and personal preferences. Shared decision-making enhances satisfaction with reconstructive decisions, but some women experience difficulty participating effectively. This study evaluated the effectiveness of a PMBR-specific patient decision aid (pDA) compared with high-quality standard care. METHODS: In this single-centre RCT, women eligible for PMBR were assigned in a 1:1 ratio to either standard care alone (control) or standard care and a pDA (intervention). Questionnaires were completed at baseline, after reconstructive decision, and at 1-year post-surgery. The primary outcome was decisional conflict after the decision. Secondary outcomes included measures for the decision-making process, patient-reported, and surgical outcomes. Between-group differences were analysed using t-tests, Mann-Whitney U tests, and chi-square tests. Mean differences (MD) with 95% confidence intervals quantified outcomes, while effect sizes were determined by Cohen's d. RESULTS: A total of 134 patients were enrolled (66 intervention, 68 control). Both groups reported consistently low decisional conflict (17 and 20 respectively). No significant differences were found in the primary (MD -2.8, 95% c.i., -8.4 to 2.8, Cohen's d -0.18) or secondary outcomes immediately after reconstructive decision or 1-year post-surgery. CONCLUSION: In a population with access to high-quality multidisciplinary care, an online pDA for PMBR did not provide additional benefits over standard care. Both approaches effectively supported reconstructive decision-making, resulting in consistently low levels of decisional conflict. TRIAL REGISTRATION NUMBER: NL-OMON28003 (NTR), NL7939 (NTR-new).
引用
- Jansen BAM, Henskens IJ, Bargon CA, et al. Effectiveness of a patient decision aid for women considering post-mastectomy breast reconstruction: randomized controlled trial. Br J Surg. 2025. PMID: 40794622. doi:10.1093/bjs/znaf151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。